Sorry, but you do not have permission to view this content.
Topic Archives:
ERIC Health Care Policy Highlights: Biosimilars Advocacy; HELP Hearing and Nominations; and More
Sorry, but you do not have permission to view this content.
ERIC Applauds Key Wins in the “One Big Beautiful Bill Act”
Washington, D.C., July 3, 2025 – Today, the U.S. House of Representatives passed the “One Big Beautiful Bill Act” (H.R. 1), marking the final vote on a broad legislative package including health and tax policy
ERIC Submits Recommendations on Implementing Prescription Drug Price Transparency
Washington, D.C., July 2, 2025 – The ERISA Industry Committee (ERIC) today submitted recommendations in response to the Request for Information on how to implement the prescription drug machine-readable file (MRF) disclosure requirements under the Transparency in Coverage (TiC) Final Rule from the Departments of Labor, Health and Human Services, and the Treasury.
ERIC Health Care Policy Highlights: Senate Passes One Big Beautiful Bill Act; Supreme Court Not Taking Up Mulready v PCMA; and More
Sorry, but you do not have permission to view this content.
ERIC Health Care Policy Highlights: Virtual Meet & Greet with Rep. Yakym; Victory! USPSTF Topic Selected; and More
Sorry, but you do not have permission to view this content.
ERIC Health Care Policy Highlights: Virtual Meet & Greet with Rep. Yakym; FTC & DOJ Listening Sessions on Lowering Drug Prices; and More
Sorry, but you do not have permission to view this content.
ERIC Health Care Policy Highlights: Sign Up for C-Suite Policy Pulse; House E&C Hearing; and More
Sorry, but you do not have permission to view this content.
Why these health provisions are critical in the “One Big Beautiful Bill Act”
As is often the case when legislation is winding its way through Congress, one or two provisions always seem to steal the headlines. Typically, these provisions illicit great controversy, significant opponents, or the potential to create ads for campaign season.
ERIC Health Care Policy Highlights: EBSA Head Nominee Hearing; Post-Chevron Senate Report; and More
Sorry, but you do not have permission to view this content.